Pancreas Cancer Program

FOR PATIENTS:
> UCSF Pancreas Center
> UCSF clinical care for pancreas cancer

> Pancreas Cancer Clinical Trials at UCSF


Program Leader

 

Image
Margaret Tempero

Margaret Tempero, MD
Director, UCSF Pancreas Center; Leader, Pancreas Cancer Program;
Professor of Medicine, Division of Hematology and Oncology, UCSF

Rombauer Family Distinguished Professorship in Pancreas Cancer Clinical and Translational Science


Funding Opportunities

    Hirshberg Foundation Seed Grant [more info]

    Deadline: August 15th

    • $40,000/1 yr, with a possibility of renewal for a second year. Open to basic and clinical faculty, or post-docs with two or more years experience.
    • See website for more information

    American Association for Cancer Research Funding Available for All Career Stages [more info]
    Deadline: varies


    Make a Gift

    Pancreatic cancer is the third most common cause of cancer death in the United States. The American Cancer Society estimates that in 2020 about 57,600 people will be newly diagnosed with pancreatic cancer and more than 47,000 people will die from the disease. Pancreatic cancer is a silent killer, as its symptoms are so insidious that most people are not diagnosed until the disease has advanced beyond the stage where surgical resection is possible. Even among surgical candidates, removal of the diseased pancreas and surrounding tissues is rarely curative. To add to this bleak picture, pancreas cancer is also noted for its intrinsic resistance to standard regimens of chemo- and radiotherapy. It is clear that new strategies to prevent, diagnose, and treat pancreas cancer are urgently required.